Cambridge Investment Research Advisors
OXLC

Cambridge Investment Research Advisors’s Oxford Lane Capital OXLC Stock Holding History

Cambridge Investment Research Advisors’s Portfolio OXLC Stock Details OXLC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,449
Closed -$416K – 4031
2025
Q4 		$416K Sell
28,449
-5,780
-17% -$86.5K ﹤0.01% 2898
2025
Q3 		$580K Sell
34,229
-11,785
-26% -$215K ﹤0.01% 2529
2025
Q2 		$966K Sell
46,014
-5,317
-10% -$119K ﹤0.01% 1981
2025
Q1 		$1.21M Buy
51,331
+6,409
+14% +$159K ﹤0.01% 1708
2024
Q4 		$1.14M Buy
44,922
+8,168
+22% +$214K ﹤0.01% 1760
2024
Q3 		$963K Buy
36,754
+29,913
+437% +$807K ﹤0.01% 1879
2024
Q2 		$185K Sell
6,841
-470
-6% -$12.4K ﹤0.01% 3062
2024
Q1 		$186K Sell
7,311
-1,207
-14% -$31K ﹤0.01% 3042
2023
Q4 		$210K Buy
8,518
+1,513
+22% +$37.3K ﹤0.01% 2863
2023
Q3 		$175K Buy
7,005
+61
+0.9% +$1.57K ﹤0.01% 2860
2023
Q2 		$168K Buy
6,944
+321
+5% +$8.2K ﹤0.01% 2918
2023
Q1 		$173K Sell
6,623
-4,110
-38% -$115K ﹤0.01% 2867
2022
Q4 		$272K Buy
10,733
+4,015
+60% +$104K ﹤0.01% 2509
2022
Q3 		$174K Sell
6,718
-2,536
-27% -$76.4K ﹤0.01% 2738
2022
Q2 		$263K Sell
9,254
-119
-1% -$3.9K ﹤0.01% 2497
2022
Q1 		$339K Sell
9,373
-18,820
-67% -$724K ﹤0.01% 2444
2021
Q4 		$1.09M Buy
28,193
+23,524
+504% +$915K ﹤0.01% 1523
2021
Q3 		$168K Buy
4,669
+988
+27% +$35.8K ﹤0.01% 2849
2021
Q2 		$136K Buy
3,681
+888
+32% +$31.1K ﹤0.01% 2920
2021
Q1 		$88K Buy
2,793
+68
+2% +$2.15K ﹤0.01% 2774
2020
Q4 		$74K Sell
2,725
-196
-7% -$4.83K ﹤0.01% 2630
2020
Q3 		$64K Buy
+2,921
New +$62.6K ﹤0.01% 2430
2020
Q2 		– Sell
-2,046
Closed -$43K – 2500
2020
Q1 		$43K Sell
2,046
-246
-11% -$9.47K ﹤0.01% 2192
2019
Q4 		$94K Sell
2,292
-13
-0.6% -$577 ﹤0.01% 2320
2019
Q3 		$107K Sell
2,305
-250
-10% -$12.6K ﹤0.01% 2223
2019
Q2 		$129K Sell
2,555
-686
-21% -$35.6K ﹤0.01% 2078
2019
Q1 		$159K Buy
3,241
+251
+8% +$12.7K ﹤0.01% 2125
2018
Q4 		$145K Sell
2,990
-825
-22% -$41.9K ﹤0.01% 1989
2018
Q3 		$202K Sell
3,815
-1,495
-28% -$81.8K ﹤0.01% 2048
2018
Q2 		$277K Buy
+5,310
New +$284K ﹤0.01% 1789
2015
Q2 		– Sell
-2,009
Closed -$149K – 1476
2015
Q1 		$149K Buy
+2,009
New +$152K ﹤0.01% 1299

Other funds holding OXLC

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EPCM
Eagle Point Credit Management Greenwich, Connecticut $76.5M AUM
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AM
Ares Management Los Angeles, California $1.52B AUM 12.97% 1-Year Est. Return

Cambridge Investment Research Advisors's OXLC Position: Q1 2026 in Review

Cambridge Investment Research Advisors sold out of Oxford Lane Capital (OXLC) in Q1 2026, closing a stake of 28,449 shares — an estimated $416K sold.

Cambridge Investment Research Advisors first reported a position in OXLC in Q1 2015 and held it in 31 quarters. The position peaked at $1.21M in Q1 2025. 87 funds tracked by Wall St. Rank hold OXLC as of Q1 2026.

  • Cambridge Investment Research Advisors reported no remaining Oxford Lane Capital position as of Q1 2026 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 28,449 Oxford Lane Capital shares in Q1 2026, an estimated $416K.
  • Cambridge Investment Research Advisors first reported a position in Oxford Lane Capital in Q1 2015 and held it in 31 quarters.
  • Cambridge Investment Research Advisors's Oxford Lane Capital position peaked at $1.21M in Q1 2025.
  • 87 funds tracked by Wall St. Rank held Oxford Lane Capital as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.